XIGDUO (Dapagliflozin & Metformin HCL)-1000mg

XIGDUO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Dapagliflozin is indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD) or multiple cardiovascular  (CV) risk factors.

Enquiry Now
Category:

Additional information

Trade Name

XIGDUO 1000mg

Generic Name

Dapagliflozin & Metformin HCL

Manufacturer

AstraZeneca Pharmaceuticals LP

Drug Type

cardiodiabetic

Indication

Antidiabetic

Doasage Form

Tablet

Packaging

4 x 14tablets 5mg/1000mg